Atea Pharmaceuticals, Inc. (AVIR)
6.05
-0.05
(-0.82%)
USD |
NASDAQ |
Mar 16, 16:00
6.06
+0.01
(+0.17%)
After-Hours: 20:00
Atea Pharmaceuticals Total Assets (Quarterly) : 315.22M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Oramed Pharmaceuticals, Inc. | 220.49M |
| Aclaris Therapeutics, Inc. | 160.46M |
| PMV Pharmaceuticals, Inc. | 116.56M |
| Instil Bio, Inc. | 211.77M |
| Alumis, Inc. | 488.01M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 39.78M |
| Shareholders Equity (Quarterly) | 275.43M |
| Debt to Equity Ratio | 0.0031 |
| Current Ratio | 7.817 |
| Net Debt Paydown Yield | 0.07% |